Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients
Pierre Sesques, Emmanuel Bachy, Emmanuelle Ferrant, Violaine Safar, Morgane Gossez, Florence Morfin, Fabienne Venet, Florence Ader
Topics & Concepts
Chimeric antigen receptorImmunotherapyCD19VirologyAntigenImmune systemImmunologyBiologyMedicineSARS-CoV-2 and COVID-19 ResearchCAR-T cell therapy researchImmunotherapy and Immune Responses